Laura Fernández Landó

7PUBLICATIONS
18CO-AUTHORS
Aboriginal and Torres Strait Islander theory of change models for healthEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersPharmaceutical delivery technologiesMedical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2024
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).

Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó

|Mar 26, 2024
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes.

Bertrand Cariou, Jennifer Linge, Ian J Neeland

|May 29, 2023
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.

Sue D Pedersen, Francesco Giorgino, Guillermo Umpierrez

|Mar 31, 2023
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3.

Adie Viljoen, Kevin M Pantalone, Rodolfo J Galindo

|Feb 14, 2019
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.

Guillermo Umpierrez, Kevin M Pantalone, Charles M Atisso

|Feb 13, 2018
Dulaglutide 1.5 mg as an add-on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration.

Kevin M Pantalone, Hiren Patel, Maria Yu

Pageof 2

Frequent Collaborators

3 joint publications

Kevin M Pantalone

3 joint publications

Hiren Patel

2 joint publications

Guillermo Umpierrez

2 joint publications

Ruth Huh